Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Masuko

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2012
Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodilHideyuki Tomitori, Akiko Suganami, Ryotaro Saiki, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 10, 2017
Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cellsRyosuke Satoh, Kanako Hagihara, Kazuki Matsuura, et al.
Cancer Science|April 14, 2012
NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvationKaori Hara, Shiho Ueda, Yoshiya Ohno, et al.
Cancer Science|July 31, 2018
Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1Yuta Hara, Ryota Torii, Shiho Ueda, et al.
Cancer Medicine|February 8, 2023
Dual-targeting therapy against HER3/MET in human colorectal cancersAkitaka Yamasaki, Rikuto Miyake, Yuta Hara, et al.
Molecular Biology of the Cell|December 25, 2009
The cell surface protein gene ecm33+ is a target of the two transcription factors Atf1 and Mbx1 and negatively regulates Pmk1 MAPK cell integrity signaling in fission yeastHirofumi Takada, Aiko Nishida, Mitsuhiro Domae, et al.
Cancer Science|August 25, 2019
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinomaShogo Okazaki, Kiyoko Umene, Juntaro Yamasaki, et al.
Cancer Science|May 14, 2016
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatmentMalinee Thanee, Watcharin Loilome, Anchalee Techasen, et al.
Cancer Research|September 26, 2019
Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell CarcinomaTakashi Sato, Seungyeul Yoo, Ranran Kong, et al.
Plos Biology|March 15, 2018
Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complexLiang Weng, Yi-Peng Han, Atsushi Enomoto, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2012
Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodilHideyuki Tomitori, Akiko Suganami, Ryotaro Saiki, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 10, 2017
Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cellsRyosuke Satoh, Kanako Hagihara, Kazuki Matsuura, et al.
Cancer Science|April 14, 2012
NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvationKaori Hara, Shiho Ueda, Yoshiya Ohno, et al.
Cancer Science|July 31, 2018
Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1Yuta Hara, Ryota Torii, Shiho Ueda, et al.
Cancer Medicine|February 8, 2023
Dual-targeting therapy against HER3/MET in human colorectal cancersAkitaka Yamasaki, Rikuto Miyake, Yuta Hara, et al.
Molecular Biology of the Cell|December 25, 2009
The cell surface protein gene ecm33+ is a target of the two transcription factors Atf1 and Mbx1 and negatively regulates Pmk1 MAPK cell integrity signaling in fission yeastHirofumi Takada, Aiko Nishida, Mitsuhiro Domae, et al.
Cancer Science|August 25, 2019
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinomaShogo Okazaki, Kiyoko Umene, Juntaro Yamasaki, et al.
Cancer Science|May 14, 2016
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatmentMalinee Thanee, Watcharin Loilome, Anchalee Techasen, et al.
Cancer Research|September 26, 2019
Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell CarcinomaTakashi Sato, Seungyeul Yoo, Ranran Kong, et al.
Plos Biology|March 15, 2018
Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complexLiang Weng, Yi-Peng Han, Atsushi Enomoto, et al.
Pageof 9